Theriva Biologics Files 8-K, Updates Address
Ticker: TOVX · Form: 8-K · Filed: Jun 20, 2025 · CIK: 894158
| Field | Detail |
|---|---|
| Company | Theriva Biologics, Inc. (TOVX) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, address-change
TL;DR
Theriva Biologics updated its address in an 8-K filing.
AI Summary
On June 20, 2025, Theriva Biologics, Inc. filed an 8-K report. The filing indicates a change in the company's business address to 9605 Medical Center Drive, Suite 270, Rockville, MD 20850. The company was formerly known as Synthetic Biologics, Inc. and has had previous name changes dating back to 2006.
Why It Matters
This filing provides an official update on Theriva Biologics' corporate address, which is important for investors and stakeholders to ensure they have the correct contact information for the company.
Risk Assessment
Risk Level: low — The filing is a routine corporate update regarding an address change and does not contain information about significant financial events or strategic shifts.
Key Players & Entities
- Theriva Biologics, Inc. (company) — Registrant
- Synthetic Biologics, Inc. (company) — Former company name
- 9605 Medical Center Drive, Suite 270, Rockville, MD 20850 (location) — New business address
- June 20, 2025 (date) — Date of report
FAQ
What is the new business address for Theriva Biologics, Inc.?
The new business address for Theriva Biologics, Inc. is 9605 Medical Center Drive, Suite 270, Rockville, MD 20850.
What was Theriva Biologics, Inc. formerly known as?
Theriva Biologics, Inc. was formerly known as Synthetic Biologics, Inc.
On what date was this 8-K report filed?
This 8-K report was filed on June 20, 2025.
In which state is Theriva Biologics, Inc. incorporated?
Theriva Biologics, Inc. is incorporated in Nevada.
What is the IRS Employer Identification Number for Theriva Biologics, Inc.?
The IRS Employer Identification Number for Theriva Biologics, Inc. is 13-3808303.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding Theriva Biologics, Inc. (TOVX).